Conte P - Search Results

1

Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis.

Buja A, Pasello G, De Luca G, Bortolami A, Zorzi M, Rea F, Pinato C, Dal Cin A, De Polo A, Schiavon M, Zuin A, Marchetti M, Scroccaro G, Baldo V, Rugge M, Guarneri V, Conte P. Buja A, et al. Among authors: conte p. JCO Oncol Pract. 2021 Aug;17(8):e1085-e1093. doi: 10.1200/OP.20.00863. Epub 2021 Apr 7. JCO Oncol Pract. 2021. PMID: 33826354

2

Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.

Baldini E, Tibaldi C, Chella A, Angeletti CA, Romanini A, Andrei A, Algeri R, Silvano G, Conte PF. Baldini E, et al. Among authors: conte pf. Semin Oncol. 1994 Jun;21(3 Suppl 4):12-5. Semin Oncol. 1994. PMID: 8209271 Clinical Trial.

3

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

Baldini E, Tibaldi C, Chella A, Angeletti CA, Silvano G, Andrei A, Algeri R, Conte PF. Baldini E, et al. Among authors: conte pf. Ann Oncol. 1996 Sep;7(7):747-9. doi: 10.1093/oxfordjournals.annonc.a010726. Ann Oncol. 1996. PMID: 8905035 Free article. Clinical Trial.

4

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.

Baldini E, Tibaldi C, Pfanner E, Ricci S, Falcone A, Ceribelli A, Sarcina R, Comella G, Stampino CG, Conte PF. Baldini E, et al. Among authors: conte pf. Am J Clin Oncol. 1996 Dec;19(6):592-4. doi: 10.1097/00000421-199612000-00013. Am J Clin Oncol. 1996. PMID: 8931679 Clinical Trial.

5

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.

Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Algeri R, Bonifazi V, Fioretto ML, Orlandini C, Conte PF. Ricci S, et al. Among authors: conte pf. Lung Cancer. 2000 Feb;27(2):75-80. doi: 10.1016/s0169-5002(99)00098-7. Lung Cancer. 2000. PMID: 10688490 Clinical Trial.

6

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).

Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R; Italian Lung Cancer Task Force. Baldini E, et al. Among authors: conte pf. Br J Cancer. 2001 Nov 16;85(10):1452-5. doi: 10.1054/bjoc.2001.2108. Br J Cancer. 2001. PMID: 11720427 Free PMC article. Clinical Trial.

7

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.

Gennari A, Guarneri V, Landucci E, Orlandini C, Rondini M, Salvadori B, Ricci S, Conte PF. Gennari A, et al. Clin Breast Cancer. 2002 Dec;3(5):346-52. doi: 10.3816/CBC.2002.n.038. Clin Breast Cancer. 2002. PMID: 12533265 Clinical Trial.

8

The curability of breast cancer and the treatment of advanced disease.

Guarneri V, Conte PF. Guarneri V, et al. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S149-61. doi: 10.1007/s00259-004-1538-5. Epub 2004 Apr 24. Eur J Nucl Med Mol Imaging. 2004. PMID: 15107948 Review.

9

Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.

Conte P, Guarneri V. Conte P, et al. Oncologist. 2004;9 Suppl 4:28-37. doi: 10.1634/theoncologist.9-90004-28. Oncologist. 2004. PMID: 15459427 Free article. Review.

10

Predictive value of biologic parameters for primary chemotherapy in operable breast cancer.

Frassoldati A, Maur M, Guarneri V, Nicolini M, Conte PF. Frassoldati A, et al. Clin Breast Cancer. 2005 Oct;6(4):315-24. doi: 10.3816/CBC.2005.n.034. Clin Breast Cancer. 2005. PMID: 16277881 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

770 results

Search Page